Literature DB >> 16492060

Protein ligand design: from phage display to synthetic protein epitope mimetics in human antibody Fc-binding peptidomimetics.

Ricardo L A Dias1, Rudi Fasan, Kerstin Moehle, Annabelle Renard, Daniel Obrecht, John A Robinson.   

Abstract

Phage display is a powerful method for selecting peptides with novel binding functions. Synthetic peptidomimetic chemistry is a powerful tool for creating structural diversity in ligands as a means to establish structure-activity relationships. Here we illustrate a method of bridging these two methodologies, by starting with a disulfide bridged phage display peptide which binds a human antibody Fc fragment (Delano et al. Science 2000, 287, 1279) and creating a backbone cyclic beta-hairpin peptidomimetic with 80-fold higher affinity for the Fc domain. The peptidomimetic is shown to adopt a well-defined beta-hairpin conformation in aqueous solution, with a bulge in one beta-strand, as seen in the crystal structure of the phage peptide bound to the Fc domain. The higher binding affinity of the peptidomimetic presumably reflects the effect of constraining the free ligand into the conformation required for binding, thus highlighting in this example the influence that ligand flexibility has on the binding energy. Since phage display peptides against a wide variety of different proteins are now accessible, this approach to synthetic ligand design might be applied to many other medicinally and biotechnologically interesting target proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492060     DOI: 10.1021/ja057513w

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  22 in total

1.  Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leads.

Authors:  Michael J Caulfield; Vadim Y Dudkin; Elizabeth A Ottinger; Krista L Getty; Paul D Zuck; Robin M Kaufhold; Robert W Hepler; Georgia B McGaughey; Michael Citron; Renee C Hrin; Ying-Jie Wang; Michael D Miller; Joseph G Joyce
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

2.  Synthesis and structure-activity relationship studies of IgG-binding peptides focused on the C-terminal histidine residue.

Authors:  Kyohei Muguruma; Mayu Ito; Akane Fukuda; Satoshi Kishimoto; Akihiro Taguchi; Kentaro Takayama; Atsuhiko Taniguchi; Yuji Ito; Yoshio Hayashi
Journal:  Medchemcomm       Date:  2019-08-01       Impact factor: 3.597

3.  Discovery and characterization of a peptide motif that specifically recognizes a non-native conformation of human IgG induced by acidic pH conditions.

Authors:  Kotaro Sakamoto; Yuji Ito; Takaaki Hatanaka; Preeti Brijiral Soni; Toshiyuki Mori; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

4.  Tracing primordial protein evolution through structurally guided stepwise segment elongation.

Authors:  Hideki Watanabe; Kazuhiko Yamasaki; Shinya Honda
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

5.  Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids.

Authors:  John R Frost; Nicholas T Jacob; Louis J Papa; Andrew E Owens; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2015-05-15       Impact factor: 5.100

6.  Ribosomal Synthesis of Natural-Product-Like Bicyclic Peptides in Escherichia coli.

Authors:  Nina Bionda; Rudi Fasan
Journal:  Chembiochem       Date:  2015-08-06       Impact factor: 3.164

7.  A Cyclic Peptide Mimic of the β-Amyloid Binding Domain on Transthyretin.

Authors:  Patricia Y Cho; Gururaj Joshi; Melissa D Boersma; Jeffrey A Johnson; Regina M Murphy
Journal:  ACS Chem Neurosci       Date:  2015-03-09       Impact factor: 4.418

8.  Cyclic modular beta-sheets.

Authors:  R Jeremy Woods; Justin O Brower; Elena Castellanos; Mehrnoosh Hashemzadeh; Omid Khakshoor; Wade A Russu; James S Nowick
Journal:  J Am Chem Soc       Date:  2007-02-13       Impact factor: 15.419

Review 9.  Synthesis of macrocyclic organo-peptide hybrids from ribosomal polypeptide precursors via CuAAC-/hydrazide-mediated cyclization.

Authors:  Jessica M Smith; Rudi Fasan
Journal:  Methods Mol Biol       Date:  2015

10.  Side-chain-to-tail cyclization of ribosomally derived peptides promoted by aryl and alkyl amino-functionalized unnatural amino acids.

Authors:  John R Frost; Zhijie Wu; Yick Chong Lam; Andrew E Owens; Rudi Fasan
Journal:  Org Biomol Chem       Date:  2016-04-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.